ChronoScale Holdings Corp (CHRN) · Oct 15, 2026 · Earnings

ChronoScale earnings surge on AI sales, but losses widen

Miss — Adjusted EBITDA $5.9M vs $9.4M prior year; no published consensus

ChronoScale earnings show explosive AI revenue growth, but deeper losses and weaker adjusted EBITDA expose the cost of scaling its compute platform.

ChronoScale is in the early build-out phase of an AI infrastructure platform, expanding GPU capacity around Microsoft, Nutanix, and Baseten relationships while moving away from its legacy Ekso business. Its Microsoft relationship covers a planned 50-megawatt AI compute deployment, while the Nutanix partnership targets enterprise AI infrastructure.

Revenue is scaling quickly, but the quarter does not yet show operating leverage. Revenue reached $41.5 million, up 148% from $16.7 million a year earlier, largely because of a new customer and AI infrastructure hardware resale activity. But cost of revenue rose to $45.6 million, already exceeding revenue, while selling, general and administrative expense jumped to $20.7 million from $0.4 million.

MetricQ1 FY2027Q1 FY2026What changed
Revenue$41.5M$16.7M+148% (Financial Highlights)
Net loss from continuing operations$(26.4)M$(11.2)MLoss more than doubled (Income Statement)
Continuing-operations loss per share$(0.18)$(0.08)Worse year over year (Income Statement)
Adjusted EBITDA$5.9M$9.4MDown from prior year (Non-GAAP reconciliation)
Operating cash flow$14.6M$0.1MImproved, helped by working capital (Cash Flow statement)
Cash from continuing operations$15.2M$0.0M shownLimited reported liquidity base (Balance Sheet)

The core scorecard is weaker than the headline growth suggests. Continuing-operations net loss widened to $26.4 million from $11.2 million, and adjusted EBITDA fell to $5.9 million from $9.4 million despite the revenue surge. There is no reliable published consensus in the available context, so the cleanest benchmark is the company’s own prior-year economics: ChronoScale is generating far more revenue, but each dollar is currently carrying heavier infrastructure and corporate costs.

Cash generation improved, but the balance sheet still leaves little room for execution mistakes. Operating cash flow was $14.6 million, mainly supported by receivables and payables movements, while cash from continuing operations ended at $15.2 million. The company also says it has received $328.2 million of customer prepayments, but those funds come with deployment obligations and potential refund, delay-credit, or penalty exposure if infrastructure is not delivered on schedule.

The strategic cleanup is real but mostly not new. ChronoScale completed the Legacy Ekso sale on September 30 and says that removes the business’s ongoing funding needs. 〔0〕 The contract extension, new customer agreement, and $1 billion annualized run-rate target were also announced before this earnings release, so the incremental news is the first reported quarter showing what scaling those commitments currently costs.

Bottom line: This is a high-growth AI infrastructure quarter with worsening underlying profitability. The business story advanced through customer commitments and cash prepayments, but the reported economics were not yet strong enough to validate the scale-up without qualification.

What to watch next

Microsoft deployment ramp and next quarterly report

Original filing on SEC EDGAR

ChronoScale earnings surge on AI sales, but losses widen | CHRN Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.